Reports for AA PHARMA INC
Company Name
AA PHARMA INC
Totals |
||
Shortage reports |
375 |
|
Actual shortage: | 28 (7%) | |
Anticipated shortage: | 2 (1%) | |
Avoided shortage: | 6 (2%) | |
Resolved: | 339 (90%) | |
Discontinuation Reports |
58 |
|
To be discontinued: | 1 (2%) | |
Discontinued: | 55 (95%) | |
Reversed: | 2 (3%) | |
Late reports |
29 (7%) |
|
Overdue reports |
14 (45%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
PINAVERIUM | 100MG | TABLET | Resolved | 2019-08-07 | 2019-08-31 | 91100 |
PINAVERIUM | 100MG | TABLET | Resolved | 2020-09-02 | 2020-10-05 | 123571 |
PINAVERIUM | 100MG | TABLET | Resolved | 2021-01-29 | 2021-02-09 | 132735 |
PINAVERIUM | 100MG | TABLET | Resolved | 2021-07-22 | 2021-08-20 | 142861 |
PINAVERIUM | 100MG | TABLET | Resolved | 2023-11-01 | 2023-12-04 | 208859 |
PINAVERIUM | 100MG | TABLET | Actual shortage | 2024-05-24 | 2024-05-24 | 228789 |
AA-RISEDRONATE DR | 35MG | TABLET (DELAYED-RELEASE) | Resolved | 2021-10-29 | 2021-11-19 | 148545 |
AA-RISEDRONATE DR | 35MG | TABLET (DELAYED-RELEASE) | Resolved | 2022-03-18 | 2022-04-06 | 156999 |
AA-RISEDRONATE DR | 35MG | TABLET (DELAYED-RELEASE) | Resolved | 2022-10-14 | 2023-01-06 | 171833 |
AA-RISEDRONATE DR | 35MG | TABLET (DELAYED-RELEASE) | Resolved | 2022-12-02 | 2022-12-23 | 176948 |
AA-RISEDRONATE DR | 35MG | TABLET (DELAYED-RELEASE) | Resolved | 2023-12-13 | 2024-02-22 | 213143 |
AA-RISEDRONATE DR | 35MG | TABLET (DELAYED-RELEASE) | Resolved | 2024-04-04 | 2024-05-30 | 224320 |
AA-THEO LA | 300MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-04-24 | 2021-10-14 | 82343 |
PENTOXIFYLLINE SR | 400MG | TABLET (EXTENDED-RELEASE) | Resolved | 2022-04-29 | 2022-07-23 | 159738 |
AA-LEVOCARB CR | 50MG 200MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-05-16 | 2017-06-02 | 10406 |
AA-LEVOCARB CR | 50MG 200MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-09-04 | 2017-10-24 | 20879 |
AA-LEVOCARB CR | 50MG 200MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-09-26 | 2017-10-24 | 23561 |
AA-LEVOCARB CR | 50MG 200MG | TABLET (EXTENDED-RELEASE) | Resolved | 2018-01-17 | 2018-03-08 | 36301 |
AA-LEVOCARB CR | 50MG 200MG | TABLET (EXTENDED-RELEASE) | Resolved | 2018-05-23 | 2018-08-21 | 50150 |
AA-LEVOCARB CR | 200MG 50MG | TABLET (EXTENDED-RELEASE) | Resolved | 2021-02-11 | 2021-08-03 | 133794 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
ORCIPRENALINE | 2MG | SYRUP | Discontinued | 2020-03-10 | 2020-03-11 | 108373 |
CIMETIDINE | 800MG | TABLET | Discontinued | 2017-03-13 | 2018-09-21 | 1061 |
TRIMIPRAMINE | 25MG | TABLET | Discontinued | 2017-03-28 | 2017-03-28 | 4528 |
ERYTHRO-BASE | 250MG | TABLET | Discontinued | 2017-03-28 | 2017-03-28 | 4584 |
IMIPRAMINE | 50MG | TABLET | Discontinued | 2017-03-28 | 2017-03-28 | 4593 |
AA-ATENIDONE | 25MG 100MG | TABLET | Discontinued | 2017-03-30 | 2018-02-05 | 4698 |
AA-ATENIDONE | 25MG 50MG | TABLET | Discontinued | 2017-03-30 | 2018-02-05 | 4702 |
AA-FENO-SUPER | 100MG | TABLET | Discontinued | 2017-03-30 | 2018-02-05 | 4710 |
ERYTHRO-S | 500MG | TABLET | Discontinued | 2017-04-02 | 2017-04-02 | 5060 |
AA-AMILZIDE | 50MG 5MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60166 |
CIMETIDINE | 600MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60376 |
DIAZEPAM | 2MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60411 |
DIAZEPAM | 5MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60414 |
DIAZEPAM | 10MG | TABLET | Discontinued | 2018-09-07 | 2018-10-05 | 60417 |
AA-DILTIAZ | 30MG | TABLET | Discontinued | 2018-09-07 | 2019-07-13 | 60429 |
AA-FENO-SUPER | 160MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60486 |
LOVASTATIN | 20MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60606 |
SULFATRIM | 400MG 80MG | TABLET | Discontinued | 2018-09-10 | 2018-11-09 | 61036 |
SULFATRIM DS | 800MG 160MG | TABLET | Discontinued | 2018-09-10 | 2018-09-15 | 61039 |
ISDN | 10MG | TABLET | Discontinued | 2018-12-20 | 2022-01-27 | 70182 |